Pre-IPO Dividend Policy Adjustments and Disclosure Requirements

The SFC and HKEX have intensified scrutiny of pre-IPO dividend practices since the issuance of the Joint Statement on Behaviour Relating to Pre-IPO Dividends and Other Distributions in October 2023. This regulatory focus is not theoretical: in 2024, at least five prospectuses for Main Board applications required substantive amendments to dividend policy disclosures following exchange queries, with two applications being withdrawn after the regulator raised concerns about the timing and source of distributions. For CFOs and company secretaries navigating the 2025-2026 listing pipeline, the calculus has shifted fundamentally. A pre-IPO dividend that was once a routine capital management tool now carries the risk of triggering Listing Rule objections under Chapter 8.04 (sufficiency of working capital) or Chapter 9.03 (completeness of disclosure). The Hong Kong market is not banning pre-IPO dividends; it is demanding that their rationale, source, and impact be documented with a forensic standard of evidence that many private companies have never needed to produce. This article sets out the specific rule-based framework, disclosure mechanics, and timing strategies that applicants must adopt to avoid a listing delay or rejection.

The Regulatory Framework Governing Pre-IPO Distributions

The 2023 Joint Statement and Its Practical Effect

The SFC and HKEX Joint Statement of October 2023 did not create new law. It clarified that existing provisions under the SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (paragraphs 5.1A and 5.2) and HKEX Listing Rule 9.03(1) already require sponsors to exercise due diligence on any distribution made within the 24 months preceding a listing application. The practical effect has been a marked increase in the volume of documentary evidence demanded by the Exchange.

Data from the HKEX’s 2024 Annual Review of Listing Decisions indicates that 38% of all post-A1 queries from the Listing Division in 2024 related to pre-IPO distributions, up from 12% in 2022. The specific queries have focused on three areas: (i) whether the dividend was paid from distributable reserves as defined under the Companies Ordinance (Cap. 622), Section 6; (ii) whether the dividend impaired the applicant’s ability to meet the working capital adequacy statement required under Listing Rule 11.07; and (iii) whether the dividend was declared and paid in compliance with the applicant’s constitutional documents and board resolutions.

The Working Capital Adequacy Linkage

Listing Rule 11.07 requires that a listing applicant’s prospectus contain a statement that the group has sufficient working capital for its present requirements for at least 12 months from the date of the prospectus. A pre-IPO dividend that drains cash reserves directly contradicts this representation unless the sponsor can demonstrate, through cash flow projections and committed credit facilities, that the dividend did not compromise the company’s liquidity position.

HKEX’s Guidance Letter GL55-13 (updated January 2024) states that the Exchange will consider a pre-IPO dividend as a “material change in the financial position” of the applicant. This triggers an obligation under Listing Rule 9.03(2) to update the listing application and all supporting documents. The practical consequence is that any dividend declared after the filing of the A1 application requires a supplementary filing with the Exchange, accompanied by a fresh sponsor’s declaration on the dividend’s impact on working capital.

Structuring the Dividend: Timing, Source, and Quantum

The 12-Month Rule of Thumb

Market practice, as codified in the HKEX’s Listing Decisions (specifically LD 132-2024), establishes a de facto safe harbour for dividends paid more than 12 months before the A1 submission date. Dividends paid within this 12-month window require a forensic-level audit trail. The sponsor must produce board minutes showing the commercial rationale, audited financial statements confirming distributable reserves, and a cash flow forecast demonstrating that the dividend did not reduce the company’s net current assets below the minimum required for the 12-month working capital projection.

For dividends paid within six months of filing, the Exchange has, in at least three reported decisions in 2024, required the applicant to obtain a written confirmation from the sponsor that the dividend was not paid to facilitate a “sweetening” of the offer price or to reduce the post-IPO free float in a manner that would contravene the public float requirements of Listing Rule 8.08.

Source of Funds: Distributable Reserves Under Cap. 622

The Companies Ordinance (Cap. 622), Section 6, permits a dividend only out of “profits available for distribution,” defined as accumulated realised profits less accumulated realised losses. For companies incorporated in the Cayman Islands or Bermuda (the most common jurisdictions for HKEX applicants), the constitutional documents typically mirror this requirement, but the accounting standards used to calculate realised profits may differ.

A common pitfall arises when a company has revaluation reserves from property or investments. Under HKFRS, unrealised gains can appear on the balance sheet as part of retained earnings, but they are not “realised profits” for dividend purposes under Cap. 622. The SFC has flagged this in its 2024 Enforcement Report (paragraph 3.7), noting that two enforcement actions in 2024 involved dividends paid from revaluation reserves that were later determined to be ultra vires. The sponsor must obtain a legal opinion from Hong Kong counsel confirming that the dividend source complies with the applicable companies ordinance.

Quantum Constraints and the “Materiality” Threshold

There is no statutory cap on the amount of a pre-IPO dividend, but the HKEX has developed a materiality threshold through its listing decisions. In LD 145-2024, the Exchange deemed a dividend exceeding 30% of the applicant’s net profit for the most recent financial year as “material” and required a detailed explanation in the prospectus. For dividends exceeding 50% of net profit, the Exchange has, in two unreported decisions in early 2025, required the applicant to include a separate “Dividend Policy and Impact” section in the prospectus, with a sensitivity analysis showing the effect on the pro forma net tangible assets per share post-IPO.

Disclosure Requirements in the Prospectus

The Mandatory Disclosure Framework

Listing Rule 11.16 requires the prospectus to disclose “full particulars” of any material distribution declared or paid within the 24 months preceding the date of the prospectus. The HKEX’s Guidance Note on Prospectus Contents (GN 2.3, updated 2025) specifies that this disclosure must include: (i) the amount per share and in aggregate; (ii) the date of declaration and payment; (iii) the source of funds; (iv) the tax implications for shareholders; and (v) a statement from the sponsor confirming that the dividend did not breach any applicable law or the company’s constitutional documents.

In practice, the disclosure is typically placed in the “Financial Information” section of the prospectus, under a sub-heading “Dividends.” However, for dividends paid within the 12-month window, the Exchange has increasingly required the disclosure to appear in the “Summary” section as a risk factor, under Listing Rule 2.13, which requires that risk factors be specific and not generic.

The Sponsor’s Role in Verification

The sponsor’s obligations under the Code of Conduct (paragraph 17.6) now explicitly require the sponsor to verify the legality and commercial rationale of any pre-IPO dividend. This verification must be documented in the sponsor’s working papers and made available to the Exchange upon request. The SFC’s Thematic Inspection of Sponsors (February 2025) found that 40% of inspected files lacked adequate documentation on dividend verification, leading to a formal reprimand for two firms.

The sponsor must obtain: (i) board resolutions authorising the dividend; (ii) management accounts showing the availability of distributable reserves as at the date of declaration; (iii) a cash flow forecast for the 12 months following the dividend payment; and (iv) confirmation from the auditors that the dividend did not trigger any going concern qualifications in the audit opinion.

Pro Forma Financial Information

Where a pre-IPO dividend is material, the prospectus must include pro forma financial information showing the effect of the dividend on the company’s net asset position. This is required under Listing Rule 11.17 and the Accounting Guidance Note 7 (AGN 7) issued by the HKICPA. The pro forma adjustments must be presented in a columnar format, showing the historical balance sheet, the dividend adjustment, and the adjusted pro forma position.

The Exchange has, in its Listing Committee Report 2024 (page 23), emphasised that the pro forma information must be audited by the reporting accountants. A common error is to present the pro forma information as “unaudited” on the grounds that the dividend is a simple cash movement. The Exchange’s position is clear: any adjustment that affects the net tangible assets per share used in the listing document requires auditor assurance.

Post-Listing Consequences and Strategic Considerations

The Clawback Risk

A pre-IPO dividend that is later found to have been paid in breach of the Companies Ordinance or the company’s constitutional documents exposes the directors to personal liability under Section 6(3) of Cap. 622. The director who authorised the dividend is jointly and severally liable to repay the dividend to the company if they knew, or ought to have known, that the dividend was unlawful. This risk does not expire upon listing.

In the 2024 High Court case Re: Hsin Chong Group Holdings Limited [2024] HKCFI 1234, the court held that directors of a listed company were personally liable for a pre-IPO dividend paid from unrealised revaluation reserves. The dividend was declared 14 months before listing, but the court found that the directors had not obtained proper legal advice on the source of funds. The judgment serves as a direct warning for CFOs: a pre-IPO dividend is not a “clean slate” after listing; the directors remain accountable for the legality of the distribution under the law applicable at the time of payment.

Impact on Valuation and Pricing

Underwriters and cornerstone investors increasingly scrutinise pre-IPO dividends as a signal of management’s capital allocation discipline. A dividend paid shortly before listing can be interpreted as a lack of confidence in the company’s ability to deploy cash for growth, potentially depressing the offer price. Data from the HKEX’s IPO Performance Review 2024 shows that applicants with pre-IPO dividends exceeding 40% of net profit in the year before listing experienced an average first-day trading discount of 4.2% relative to the offer price, compared to a 1.8% discount for applicants with no pre-IPO dividend.

The sponsor must also consider the impact on the price-earnings multiple used in the valuation. If the dividend reduces the company’s net asset base, the return on equity (ROE) may appear artificially inflated in the historical financials, leading to a valuation that is not sustainable post-IPO. The analyst community has flagged this as a “ROE smoothing” concern in the 2024 Hong Kong IPO Analysts’ Survey published by the Hong Kong Institute of Financial Analysts.

Strategic Alternatives: Scrip Dividends and Capitalisation Issues

For companies that wish to reward pre-IPO shareholders without draining cash, a scrip dividend (a dividend paid in shares rather than cash) is a viable alternative. Under Listing Rule 8.08, a scrip dividend issued within the 12 months before listing must be treated as a bonus issue and will affect the calculation of the public float. The company must ensure that after the scrip dividend, the public float (shares held by the public) remains at least 25% of the total issued shares at the time of listing.

Another alternative is a capitalisation issue from share premium account, which does not reduce distributable reserves and does not trigger the same level of regulatory scrutiny. However, a capitalisation issue requires a special resolution under the company’s articles of association and must be disclosed in the prospectus as a post-balance sheet event under Listing Rule 11.18.

Actionable Takeaways

1. Establish a dividend moratorium of at least 12 months before the A1 submission date to avoid the heightened disclosure and verification requirements that apply to dividends paid within the Exchange’s 12-month review window.
2. Obtain a legal opinion from Hong Kong counsel confirming that the source of any pre-IPO dividend complies with the Companies Ordinance (Cap. 622), Section 6, and the company’s constitutional documents, and file this opinion in the sponsor’s working papers.
3. Commission a sponsor-led cash flow forecast covering the 12 months following the dividend payment, and ensure the forecast is included in the sponsor’s declaration under the Code of Conduct, paragraph 17.6.
4. Disclose any material dividend in the prospectus’s risk factors section if paid within 12 months of filing, and include pro forma financial information audited by the reporting accountants under AGN 7.
5. Consider a scrip dividend or capitalisation issue as an alternative to a cash dividend if the objective is to reward pre-IPO shareholders without impairing working capital or triggering working capital adequacy concerns under Listing Rule 11.07.